{
    "2019-03-15": [
        [
            {
                "time": "",
                "original_text": "渤海证券医药行业二季度投资策略报告：着眼精品，强者恒强",
                "features": {
                    "keywords": [
                        "渤海证券",
                        "医药行业",
                        "二季度",
                        "投资策略",
                        "精品",
                        "强者恒强"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级] 医药生物-医保目录调整将至 继续深化“腾笼换鸟”",
                "features": {
                    "keywords": [
                        "推荐评级",
                        "医药生物",
                        "医保目录",
                        "调整",
                        "腾笼换鸟"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}